Form 4 for XRAY DENTSPLY SIRONA Inc.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0000818479-26-000101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-04 | XRAY | Scavilla Daniel T | Pres, CEO, Member of BOD, Dir | A - Grant | $0.00 | +145.1K | 161.8K | +866% | $0 |
| D | 2026-03-06 | 2026-03-04 | XRAY | Scavilla Daniel T | Pres, CEO, Member of BOD, Dir | A - Grant | $0.00 | +2.07M | 2.07M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | A | A | 145,089 | $0.00 | 161,839.07 | D | — | — | (F1) Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-04 | A | A | 2,066,600 | $0.00 | 2,066,600 | D | $15.46 · 2027-03-04 to 2036-03-04 | 2,066,600 Common Stock | (F2) Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 115% of the closing price of the Issuer's common stock as of the date of grant. |